Salud financiera de hoja de balance de Brii Biosciences
Salud financiera controles de criterios 6/6
Brii Biosciences has a total shareholder equity of CN¥3.1B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥3.2B and CN¥111.6M respectively.
Información clave
0%
Ratio deuda-patrimonio
CN¥0
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | CN¥2.74b |
| Patrimonio | CN¥3.09b |
| Total pasivo | CN¥111.58m |
| Activos totales | CN¥3.20b |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
Análisis de la situación financiera
Pasivos a corto plazo: 2137's short term assets (CN¥2.8B) exceed its short term liabilities (CN¥111.6M).
Pasivo a largo plazo: 2137 has no long term liabilities.
Historial y análisis de deuda-patrimonio
Nivel de deuda: 2137 is debt free.
Reducción de la deuda: 2137 had no debt 5 years ago.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: 2137 has sufficient cash runway for more than 3 years based on its current free cash flow.
Pronóstico de cash runway: 2137 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 18.7% each year